Doctor profile · Federal record

Dr. Sara Givens, PA-C

Physician Assistant · Tallahassee, FL

  • NPI 1679166128
  • Accepts Medicare
  • MIPS 84.6 / 100 · 2023
  • 6 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1704 Riggins RD
Tallahassee, FL 323085318
(850) 877-4134
Additional location
248 Ne Hancock Ave
Madison, FL 323402560
Mailing address
Po Box 13859
Tallahassee, FL 323173859

Credentials & registration

NPPES · NUCC
NPI registered
February 2021 — 5 yrs on file
Profile last updated
February 17, 2021
Year of graduation
2020 — 6 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Florida #PA9113990

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1679166128. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
7,411
Distinct HCPCS
10
Medicare allowed
$135,107
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 4,400 22 $2
17003 Destruction of precancer skin growth, 2-14 growths 1,280 211 $5
11103 Biopsy of related skin growth, each additional growth 361 179 $41
11102 Biopsy of related skin growth, first growth 339 275 $72
17000 Destruction of precancer skin growth, 1 growth 309 243 $34
99213 Established patient office or other outpatient visit, 20-29 minutes 239 193 $75
99214 Established patient office or other outpatient visit, 30-39 minutes 223 188 $106
17110 Destruction of skin growth, 1-14 growths 122 106 $89
99203 New patient office or other outpatient visit, 30-44 minutes 44 44 $94
99204 New patient office or other outpatient visit, 45-59 minutes 43 43 $140

In context: peer comparison

Among 38 peers in Tallahassee Physician Assistant, average services per provider: 131. This provider delivers 57× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,761
Transactions
102
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 13 $411.52
Abbvie INC. 20 $380.57
Arcutis Biotherapeutics, INC. 3 $362.51
Genzyme Corporation 6 $348.80
Incyte Corporation 4 $319.25
Ucb, INC. 16 $289.12
Lilly USA, LLC 12 $262.81
E.R. Squibb & Sons, L.L.C. 4 $257.24
Novartis Pharmaceuticals Corporation 2 $215.49
Janssen Scientific Affairs, LLC 2 $204.93
Mayne Pharma Commercial LLC 7 $196.11
Pfizer INC. 8 $146.15
Leo Pharma INC. 2 $107.86
Dermavant Sciences, INC. 1 $56.69
Regeneron Healthcare Solutions, INC. 2 $39.01

By nature of payment

Food and Beverage
$3,616
Education
$145

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
868
Patients
560
Total drug cost
$50,198
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 181 148 $2,767
Fluconazole Generic 172 72 $2,218
Ciclopirox (Ciclopirox Olamine) Brand 104 78 $2,946
Hydrocortisone Generic 83 63 $692
Doxycycline Hyclate Generic 65 47 $2,684
Fluocinonide Generic 53 38 $2,829
Levocetirizine Dihydrochloride Generic 48 26 $2,333
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 45 33 $2,510
Fluocinolone Acetonide (Fluocinolone/Shower CAP) Brand 25 12 $2,379
Prednisone Generic 24 14 $146

Frequently asked questions

Auto-generated from federal data
What is Dr. Sara Givens's medical specialty?
Dr. Sara Givens practices Physician Assistant in Tallahassee, FL.
Where does Dr. Sara Givens practice?
Dr. Sara Givens practices at 1704 Riggins RD, Tallahassee, FL 323085318. Office phone: 8508774134.
What is Dr. Sara Givens's NPI?
Dr. Sara Givens's National Provider Identifier (NPI) is 1679166128, issued by NPPES.
Does Dr. Sara Givens accept Medicare assignment?
Yes. Dr. Sara Givens accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sara Givens commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, each additional growth (HCPCS 11103). Source: CMS Medicare Physician & Other Practitioners file.